Stem Cell Therapy for Ataxia Cost in Tijuana, Mexico

In 2026, ataxia stem cell therapy in Tijuana typically costs between $15,000 and $25,000. Prices vary based on the specific cell count and the number of treatment sessions required.

Tijuana offers competitive pricing by reducing administrative overhead while maintaining high medical standards. Patients can save up to 70% compared to treatment costs in the United States.

Stem cell protocols in Tijuana address various forms, including Friedreich’s ataxia and cerebellar ataxia, aiming to improve motor coordination and slow the progression of symptoms.

Most international patient packages in Tijuana are all-inclusive, covering the initial medical evaluation, cell administration, and follow-up assessments within the quoted price.

Clinics primarily utilize umbilical cord-derived mesenchymal stem cells (UC-MSCs). These are preferred for their high potency, safety profile, and regenerative potential in neurological repair.

Patients generally stay in Tijuana for 3 to 5 days. This duration allows for comprehensive pre-treatment screening, the procedure itself, and a period of observation for safety.

Yes, stem cell therapies in Mexico are regulated by COFEPRIS, the national health authority. This ensures facilities meet strict sanitary and safety standards for regenerative medicine.

Pricing depends on the total number of mesenchymal stem cells administered, the delivery method used, such as IV or intrathecal, and the inclusion of supportive therapies.

Most insurance providers categorize stem cell therapy for ataxia as experimental, so it is rarely covered. Tijuana clinics offer transparent, out-of-pocket pricing for global patients.

Many patients report improvements in balance, speech clarity, and limb coordination. Results vary, but the primary goal is enhancing quality of life and regaining lost functions.

Tijuana remains more affordable than many European centers for regenerative medicine. The proximity to the US border also significantly reduces travel-related expenses for North Americans.

Doctors typically use intravenous infusions or intrathecal injections to deliver cells. These methods help the stem cells reach the central nervous system to target neural degeneration.